WASHINGTON, Sept. 26, 2018 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it
will participate at the following upcoming 2018 investor
conferences:
The Oppenheimer Fall Summit Focused on Specialty Pharma &
Rare Disease in New York City on
Thursday, September 27, 2018.
Vanda management will host investor meetings.
The Cantor Fitzgerald Global Healthcare Conference in
New York City on Tuesday, October 2, 2018. A corporate
presentation is scheduled for 1:05 p.m.
Eastern Time.
The corporate presentation given at the Cantor Fitzgerald Global
Healthcare Conference will be available live on Vanda's corporate
website, where it also will be archived for 30 days. To access the
presentation, go to Vanda's website at www.vandapharma.com and
click on the Presentations tab on the Investor Relations page.
Please connect to the website several minutes prior to the start of
the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-oppenheimer-and-cantor-fitzgerald-fall-2018-investor-conferences-300719684.html
SOURCE Vanda Pharmaceuticals Inc.